RNA
#3713
Atrium Therapeutics, Inc. - Common Stock
8.3 1 USD
-0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.07%
Variazione Mensile
-19.86%
Variazione di 6 mesi
-34.41%
Variazione Annuale
-88.18%
Chiusura Precedente
8.4 0
Open
8.4 0
Minimo
8.3 1
Massimo
8.4 8
Financials
- Market Capitalization 142.15 M
- Employee 391
- Founded 2025
- CEO Troy Wilson
- Website www.aviditybiosciences.com
- Headquarter Delaware, United States
- FIGI BBG01Z0T3959
- Industry Biotecnologia
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3707 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 0.57 USD | -5.00% | -3.39% | -12.31% | +38.18% | 138.77 M USD | ||
| 3710 |  ARMP Armata Pharmaceuticals, Inc. Common Stock | 3.69 USD | +1.10% | +2.22% | -40.77% | -54.85% | 137.20 M USD | ||
| 3722 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.52 USD | -6.17% | -6.17% | -18.28% | -24.38% | 142.45 M USD | ||
| 3732 |  TLSA Tiziana Life Sciences Ltd - Common Shares | 1.12 USD | -5.88% | 0.00% | +16.67% | -45.37% | 134.97 M USD |